Side Effects of Flomax Linked to Severe Hypotension in Men: Study

According to the findings of new research, the prostate drug Flomax may put men at an increased risk for severe hypotension when the treatment is first started.  

In a study published in the British Medical Journal on November 5, researchers from the FDA and universities in the U.S. and Canada indicate that Flomax side effects may cause older men to experience a spike in hypotension risk during the first eight weeks of treatment.

Flomax (tamsulosin) is an elective medication used to treat urinary problems in men with enlarged prostates. It is prescribed to reduce difficulties like frequent urination, urgent need to urinate and waking up during the night. It was introduced in 1997 by Boehringer Ingelheim and generated sales in excess of $1 billion in 2008.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The researchers in this study looked at paid claims from more than 102 healthcare plans involving more than 300,000 patients and identified men between the ages of 40 and 85 who were diagnosed with benign prostatic hyperplasia, or an enlarged prostate from January 2011 through June 2011. They compared men who took Flomax with those who took drugs like Proscar and Avodart.

According to the findings, men who took Flomax suffered 42.4 severe hypotension events per 10,000 person years, compared to 31.3 events per 10,000 person years for drugs like Proscar. The researchers say the data indicates that the risk of severe hypotension linked to Flomax use doubles in the first four weeks of treatment and is 50% higher through weeks five through eight before dropping to normal levels.

Men who were taken off Flomax and later restarted it saw similar increased risks when treatment began anew.

“This association suggests that physicians should focus on improving counseling strategies to warn patients regarding the ‘first dose phenomenon’ with tamsulosin,” the researchers concluded. They also noted that drugs linked to similar risks carry black box warnings about hypotension; the strongest label warnings the FDA can require a drug to carry.

Although Flomax warnings are included on the label about the risk of hypotension, it is not placed in a black box and information on a potential “first dose phenomenon” is not provided, researchers note.

Hypotension is low blood pressure, which can lead to reduced oxygen to the brain and vital organs and in severe cases can send victims into shock.

Side effects of Flomax have also been linked to eye problems after cataract surgery, potentially causing a complication known as Intraoperative Floppy Iris Syndrome (IFIS). According to a study published in The Journal of the American Medical Association in May 2009, the risk of eye problems from Flomax may be more substantial than previously indicated by the manufacturer.

While the Flomax eye problems were most severe when the drug was used two weeks before cataract surgery, the study suggested Flomax can cause problems even when patients have ceased using it up to a year before surgery. Approximately 2 million cataract surgeries are performed each year in the United States, and most involve older individuals.

Image Credit: |


  • A. D. SharpeMay 7, 2015 at 6:25 pm

    Tamsulosin + a BP drug like Bystolic will put you in the floor. And, not just when you begin taking it, but later on. When I could recover enoogh to walk 3 steps and sit down, my BP reading was 58/28. If taken for BPH, you WILL pee every 90 minutes during the night.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted yesterday)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 3 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.